Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-14-071797
Filing Date
2014-10-15
Accepted
2014-10-15 16:31:59
Documents
1
Period of Report
2014-10-09

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 1478
  Complete submission text file 0001104659-14-071797.txt   2899
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Issuer) CIK: 0001080014 (see all company filings)

EIN.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address THERAVANCE, INC. 951 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address
dEsparbes Eric (Reporting) CIK: 0001622268 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-30319 | Film No.: 141157902